HOME > お知らせ > 新着情報 > 新規論文 > Novel Index based on inflammatory markers correlates with treatment efficacy of nivolumab for recurrent/metastatic head and neck cancer.

お知らせ

Novel Index based on inflammatory markers correlates with treatment efficacy of nivolumab for recurrent/metastatic head and neck cancer.

新規論文のご報告になります。

当科の多田先生の論文が掲載されました。

Tada H, Kawabata-Iwakawa R, Takahashi H, Chikamatsu K. Novel Index based on inflammatory markers correlates with treatment efficacy of nivolumab for recurrent/metastatic head and neck cancer. Oncology 2024 Nov 20:1-22.

多田先生おめでとうございます!

トップへ戻る